Chapter 5

Neuro-vestibular and Vision Changes

Navigating spatial disorientation and the critical mystery of vision impairment

The Vestibular System and Spatial Orientation

The vestibular system—housed in the inner ear—is humanity's primary sensor for gravity, acceleration, and head motion. Three semicircular canals detect rotational movement, while two otolith organs (utricle and saccule) sense linear acceleration and head tilt relative to gravity. This information integrates with visual and proprioceptive inputs to create our sense of balance and spatial orientation.

In microgravity, the otolith organs no longer sense a consistent "down" direction. The semicircular canals still detect rotation, but without gravitational context, the brain struggles to interpret signals. This sensory conflict triggers a cascade of effects: space motion sickness, spatial disorientation, and eventually neuroplastic adaptation as the brain learns to function without gravitational cues.

Space Motion Sickness: The Adaptation Syndrome

Space Adaptation Syndrome (SAS), commonly called space motion sickness, affects 60-80% of astronauts during the first 2-4 days in orbit. Symptoms include nausea, vomiting, headache, malaise, and drowsiness—remarkably similar to motion sickness on Earth but triggered by a different mechanism.

Phase	Timing	Symptoms	Mechanism
Acute	First 6-12 hours	Mild discomfort, disorientation	Initial vestibular-visual mismatch
Peak	12-72 hours	Nausea, vomiting, headache, malaise	Maximal sensory conflict
Adaptation	3-5 days	Gradual symptom resolution	Central nervous system recalibration
Adapted	5+ days	Symptom-free	New internal model of microgravity

Sensory Conflict Theory

The prevailing explanation for SAS is the sensory conflict theory. On Earth, visual, vestibular, and proprioceptive systems provide concordant information about body orientation. In microgravity, these systems send conflicting signals. The vestibular system reports no gravitational vertical, visual cues may indicate one orientation while the body "feels" another, and proprioceptors no longer sense weight loading.

The brain interprets this unprecedented sensory mismatch as possible poisoning—an evolutionary adaptation where toxins causing disorientation trigger vomiting to expel the toxin. Though no toxin exists, the nausea and vomiting response activates anyway. Over several days, the brain builds a new internal model compatible with microgravity, and symptoms resolve.

Countermeasures and Management

Pharmacological options include promethazine (antihistamine), scopolamine (anticholinergic), and ondansetron (serotonin antagonist). These medications reduce symptoms but can cause drowsiness, dry mouth, and cognitive impairment—problematic during critical mission phases. Non-pharmacological approaches include avoiding rapid head movements, using visual references, and pre-flight adaptation training.

The Autogenic Feedback Training Exercise (AFTE) protocol, developed at NASA, uses biofeedback and visualization to help astronauts consciously control autonomic responses. Studies show modest effectiveness, reducing symptom severity and duration for some individuals.

Spatial Disorientation and Neurovestibular Adaptation

Beyond motion sickness, astronauts report profound changes in spatial perception. Without "up" or "down," the concept of orientation becomes fluid. Astronauts may feel they are constantly falling, experience visual illusions, or have difficulty coordinating movement. The brain gradually adapts by relying more heavily on visual cues and learning to suppress vestibular signals.

Spaceflight-Associated Neuro-Ocular Syndrome (SANS)

In 2005, astronauts began reporting vision changes during long-duration ISS missions. Initially dismissed as routine presbyopia (age-related farsightedness), the pattern proved more concerning: 60-70% of astronauts experience vision deterioration, some with permanent damage. This constellation of findings—optic disc edema, globe flattening, choroidal folds, and cotton wool spots—is now termed Spaceflight-Associated Neuro-Ocular Syndrome (SANS).

Ocular Findings

Comprehensive ophthalmologic examinations using optical coherence tomography (OCT), fundus photography, and ultrasound reveal multiple structural changes:

Finding	Prevalence	Description	Clinical Significance
Optic Disc Edema	~40%	Swelling of optic nerve head	Indicates elevated intracranial pressure
Globe Flattening	~30%	Posterior eye shape changes	Causes hyperopic shift (farsightedness)
Choroidal Folds	~25%	Wrinkles in vascular layer	Suggests external compression or fluid shifts
Cotton Wool Spots	~20%	Retinal nerve fiber layer infarcts	Indicates ischemia or elevated pressure
Hyperopic Shift	~60%	+0.5 to +1.75 diopter change	Impairs near vision, reading difficulty
Retinal Nerve Fiber Thickening	~50%	OCT-measured layer expansion	Suggests axonal swelling or edema

The Intracranial Pressure Hypothesis

The leading theory proposes that headward fluid shifts in microgravity increase intracranial pressure (ICP), which in turn increases pressure in the optic nerve sheath and around the eye. This elevated pressure compresses the posterior globe (causing flattening), impedes venous drainage from the optic nerve (causing edema), and mechanically distorts ocular structures (causing choroidal folds).

Evidence supporting this hypothesis includes lumbar puncture measurements showing mildly elevated cerebrospinal fluid opening pressures in some astronauts post-flight, similarity to terrestrial idiopathic intracranial hypertension (pseudotumor cerebri), and animal studies showing that head-down bed rest (which simulates fluid shifts) produces similar changes.

Alternative Hypotheses

While elevated ICP is the primary theory, alternatives include carbon dioxide effects (ISS CO₂ levels are elevated, which could affect cerebral blood flow and ICP), venous congestion without ICP elevation, primary vascular changes from microgravity, and genetic susceptibility factors. Research is ongoing to definitively prove the mechanism—essential for developing effective countermeasures.

Current Countermeasures

Without certainty about the mechanism, countermeasure development is challenging. Approaches under investigation include:

• Lower Body Negative Pressure (LBNP): Devices that create suction around the legs, pulling fluid downward to counteract headward shifts
• Thigh cuffs: Inflatable cuffs worn on the upper thighs to occlude venous return, creating fluid pooling in the legs
• Elevated CO₂ scrubbing: Maintaining ISS CO₂ below current levels to reduce potential vascular effects
• Nutrition: Sodium restriction and folate/vitamin B supplementation based on limited evidence
• Custom eyewear: Corrective lenses (both glasses and contact lenses) to compensate for hyperopic shift

So far, no countermeasure has proven definitively effective at preventing SANS. This remains one of the highest-priority research areas in space medicine.

Post-Flight Readaptation Challenges

Upon return to Earth, astronauts must readapt to gravity—a process that mirrors the initial adaptation to microgravity. Sensorimotor coordination is impaired: simple tasks like walking, climbing stairs, or catching a ball require conscious effort. Balance and postural control are disrupted, with some astronauts describing feeling "drunk" or having difficulty standing still with eyes closed.

Implications for Planetary Exploration

The transition from microgravity to Mars (0.38 g) or Moon (0.17 g) gravity will present unique challenges. Will astronauts experience motion sickness when transitioning from zero-g to partial gravity? How quickly will they adapt? Will partial gravity slow or prevent SANS development? These questions can only be answered through actual missions or by building partial-gravity research facilities—neither of which currently exist.